Canada Artificial Intelligence in Healthcare Market Trends, Growth & Future Outlook 2033


The Canada artificial intelligence in healthcare market size reached USD 163.80 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 3,321.44 Million by 2033

.

IMARC Group has recently released a new research study titled “Canada Artificial Intelligence in Healthcare Market Size, Share, Trends and Forecast by Offering, Technology, Application, End User and Region, 2025-2033,” which offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.

Canada Artificial Intelligence in Healthcare Market Overview

The Canada artificial intelligence in healthcare market size reached USD 163.80 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 3,321.44 Million by 2033, exhibiting a growth rate (CAGR) of 36.81% during 2025-2033.

Market Size and Growth

Base Year: 2024

Forecast Years: 2025-2033

Historical Years: 2019-2024

​Market Size in 2024: USD 163.80 Million

​Market Forecast in 2033: USD 3,321.44 Million

Market Growth Rate 2025-2033: 36.81%

Request for a sample copy of the report: https://www.imarcgroup.com/canada-artificial-intelligence-in-healthcare-market/requestsample

Key Market Highlights:

✔️ Rapid digital transformation across healthcare systems is accelerating AI adoption for diagnostics, treatment planning, and patient monitoring

✔️ Increasing government and private investments are supporting AI-driven medical innovations and research

✔️ Growing integration of machine learning in medical imaging, virtual care, and hospital workflow automation is improving clinical outcomes and operational efficiency

Canada Artificial Intelligence in Healthcare Market Trends

The Canada Artificial Intelligence in Healthcare Market is undergoing significant transformation, influenced by new regulations and increasing reliance on digital health solutions. The Artificial Intelligence and Data Act (AIDA) has set stricter standards, while privacy concerns in 2024 prompted Health Canada to accelerate AI diagnostic approvals. This regulatory shift drove a 40% year-over-year increase in AI-assisted imaging. 

Provincial initiatives such as Ontario’s $120 million AI Health Fund have strengthened partnerships between startups and hospital networks. Meanwhile, rising demand for AI-powered remote patient monitoring—up 55% since 2024—reflects both an aging population and ongoing physician shortages. Still, fragmented interprovincial data-sharing policies hinder scalability, pushing providers toward hybrid cloud solutions. Ethical concerns, particularly regarding algorithmic bias in Indigenous healthcare, are expected to remain central to future Canada Artificial Intelligence in Healthcare Market Trends.

Market Size and Key Growth Segments

A major driver of Canada Artificial Intelligence in Healthcare Market Growth is precision oncology. In 2024, AI-based genomic tools captured 32% of the market, supported by national projects like the Pan-Canadian Genome Library, which applies federated learning to analyze more than 500,000 patient genomes while safeguarding privacy. Pharmaceutical companies, including Roche, invested over $200 million in AI for drug discovery, particularly targeting rare diseases. 

Real-world evidence platforms such as BlueDot are improving outbreak prediction, though data silos between hospitals and universities remain a hurdle. In rural Canada, AI adoption lags, with telehealth usage at only 15% despite government-led broadband expansion. Surgical robotics is playing an increasingly important role in the Canada Artificial Intelligence in Healthcare Market outlook. Advances in haptic feedback and computer vision in 2024 reduced cardiac intervention errors by 60% and cut recovery times by nearly one-third. 

eyond surgery, AI is streamlining hospital operations, optimizing billing and scheduling systems, and saving an estimated $380 million annually. Voice-enabled AI tools also assist nurses with real-time documentation, boosting workflow efficiency. However, rising supply chain costs and global chip shortages increased robotics prices, limiting adoption in smaller healthcare facilities. 

Cybersecurity risks add another layer of challenge, with Quebec hospitals experiencing high-profile breaches that revealed vulnerabilities in AI-driven systems. Meanwhile, a shortage of domestic AI talent—exacerbated by a 75% migration of developers to the U.S.—continues to strain innovation capacity.

Emerging Canada Artificial Intelligence in Healthcare Market Trends

A defining shift in the Canada Artificial Intelligence in Healthcare Market trends is the move from diagnostics to predictive care. AI systems are now being used to forecast ICU bed shortages and anticipate complications in chronic illnesses like diabetes. Alberta’s $90 million investment in AI ethics research highlights the growing importance of responsible innovation, while federal efforts to fast-track radiology AI tools continue. Cloud-based AI adoption surged 48% in 2024 as hospitals sought scalable solutions amid delays in robotic deployments. Increasing regulatory alignment with U.S. and EU frameworks is also creating new opportunities for Canadian healthcare AI exports, though cross-border compliance and data sovereignty remain pressing issues.

Canada Artificial Intelligence in Healthcare Market Future Outlook

The Canada Artificial Intelligence in Healthcare Market outlook suggests steady expansion through 2025 and beyond. Decentralized clinical trials for rare diseases, Indigenous-led data governance initiatives, and stronger oversight on algorithmic fairness are expected to guide the next stage of development. Despite challenges such as workforce shortages and cybersecurity risks, collaboration between government, industry, and academia is positioning Canada as a regional leader. With rising Canada Artificial Intelligence in Healthcare Market Demand and supportive policies, the sector is poised for sustained growth and innovation.

Canada Artificial Intelligence in Healthcare Market Segmentation:

The market report segments the market based on product type, distribution channel, and region:

Breakup by Offering:

  • Hardware
  • Software
  • Services

Breakup by Technology:

  • Machine Learning
  • Context Aware Computing
  • Natural Language Processing
  • Others

Breakup by Application:

  • Robot-Assisted Surgery
  • Virtual Nursing Assistant
  • Administrative Workflow Assistance
  • Fraud Detection
  • Dosage Error Reduction
  • Clinical Trial Participant Identifier
  • Preliminary Diagnosis
  • Others

Breakup by End User:

  • Healthcare Providers
  • Pharmaceutical and Biotechnology Companies
  • Patients
  • Others

Breakup by Region:

  • Ontario
  • Quebec
  • Alberta
  • British Columbia
  • Others

Ask Analyst Browse Full Report with TOC List of Figures: https://www.imarcgroup.com/request?type=reportid=28900flag=C

Competitive Landscape:

The market research report offers an in-depth analysis of the competitive landscape, covering market structure, key player positioning, top winning strategies, a competitive dashboard, and a company evaluation quadrant. Additionally, detailed profiles of all major companies are included.

Key Highlights of the Report

  1.     Market Performance (2019-2024)
  2.     Market Outlook (2025-2033)
  3.     COVID-19 Impact on the Market
  4.     Porter’s Five Forces Analysis
  5.     Strategic Recommendations
  6.     Historical, Current and Future Market Trends
  7.     Market Drivers and Success Factors
  8.     SWOT Analysis
  9.     Structure of the Market
  10. Value Chain Analysis
  11. Comprehensive Mapping of the Competitive Landscape

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91-120-433-0800

United States: +1 201971-6302

Reacties